Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
Bayer’s New American CEO to Study Wounded Pharma Giant Before Acting
Business Europe Bill Anderson aims to drive innovation and cultural change and lauds ‘compelling logic’ of Monsanto acquisition Source link
They Took This Drug to Fight Aging. But Does It Actually Work?
An antiaging crowd latched onto the diabetes drug metformin hoping it would extend lifespan. Studies give conflicting results. Source link
Hype Around Weight-Loss Drugs Shows No Signs of Abating. Neither Do the Ads.
Ads for the likes of Ozempic and Wegovy are spreading through social media feeds, subway stations and TV. Source link
Johnson & Johnson Proposes Paying $9 Billion to Settle Talc Lawsuits
A unit of the health-products company is also refiling for bankruptcy protection to seek approval for the settlement plan. Source link
The 'King Kong' of Weight-Loss Drugs Is Coming
Eli Lilly’s Mounjaro could outpace Ozempic as the most powerful treatment on the market. To develop it, the drug company needed to overhaul long-held but
Unusual Call Option Trade in Phathom Pharmaceuticals (PHAT) Worth $80.49K
On March 31, 2023 at 14:41:46 ET an unusually large $80.49K block of Call contracts in Phathom Pharmaceuticals (PHAT) was bought, with a strike price
Telemedicine Startups Wary of Regulatory Shift in War on Opioid Addiction
Telemedicine companies are facing a regulatory shift that many entrepreneurs say would undercut their ability to quickly prescribe medication that helps prevent opioid overdoses. During
Americans to Be Barred From Buying Ozempic in British Columbia
Provincial health officials urged doctors and pharmacists to make sure people are taking the drug to treat diabetes, not lose weight. Source link
Ex-FDA Official Says Baby-Formula Industry Remains Vulnerable to Problems
Politics Health Policy Poor internal communication hindered FDA’s response to crisis, former deputy commissioner says in congressional testimony Source link
Drug Middlemen Accused of Price Fixing by Ohio Attorney General
The state’s lawsuit alleged certain pharmacy-benefit managers shared drug pricing and other information to gain leverage during rebate negotiations with pharmaceutical companies. Source link
